Tarek Mohamed
Tarek Mohamed has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hamza Mohamed
Faculty of Medicine, Assiut University, Assiut, Egypt
2 shared publications - Ahmed Hassab El-Naby
Urology Department, Faculty of medicine, Assiut University, Assiut, Egypt
1 shared publication - Ahmed S. Elazab
Urology Department, Faculty of Medicine Assiut University Assiut Egypt
1 shared publication Baha’ Aldeen Bani Irshid
Princess Basma Teaching Hospital, Irbid, Jordan
1 shared publication- Mahmoud M. Shalaby
Urology Department, Faculty of Medicine Assiut University Assiut Egypt
1 shared publication Mohamed Ahmed Abdelrahman
Urology Department, Faculty of Medicine Assiut University Assiut Egypt
1 shared publication
Latest Publications
- 11 August 2026
- Published by Wiley in Neurourology and Urodynamics
Laparoscopic Burch Colposuspension Versus Transobturator Tape for the Treatment of Stress Urinary Incontinence in Egyptian Women: A 12‐Month Randomized Controlled Trial
Aims: This study aimed to compare the efficacy, safety, and patient‐reported outcomes of laparoscopic Burch colposuspension versus the transobturator tape (TOT) midurethral sling procedure for treating stress urinary incontinence (SUI) in Egyptian women. Methods: This was a randomized, open‐label clinical trial conducted in Assiut, Egypt between January 2021 and December 2023. Fifty‐two women with SUI were randomly assigned to two groups of 26 patients each: Group A underwent the TOT procedure, and Group B underwent laparoscopic Burch colposuspension. The primary outcome was the improvement of SUI, assessed by a cough stress test. Secondary outcomes included changes in symptom severity and quality of life, measured by the Urogenital Distress Inventory (UDI‐6) and the Incontinence Impact Questionnaire (IIQ‐7). Patients were evaluated at 3, 6, and 12 months postoperatively. Results: Operative and anesthesia times were significantly longer for the laparoscopic colposuspension group ( p < 0.001). At 12 months, the treatment failure rate was significantly higher in the colposuspension group (34.6%) compared to the TOT group (7.7%) ( p = 0.017). While both groups initially improved, the SUI subscale scores on the UDI‐6 for the colposuspension group worsened after 3 months, becoming significantly worse than the TOT group at 6 and 12 months ( p = 0.004 at 12 months). Similarly, at 12 months, the TOT group reported significantly better quality‐of‐life scores on the IIQ‐7 ( p = 0.04). Multivariate binary logistic regression identified laparoscopic Burch colposuspension as a significant predictor of treatment failure (Odds Ratio: 7.02, p = 0.01). Overactive bladder was more common after TOT, whereas recurrence was more frequent after colposuspension ( p = 0.02). Conclusions: While both procedures initially improve SUI, the TOT procedure provides superior and more sustained efficacy over a 12‐month period in this cohort of Egyptian women. The TOT group had a significantly lower treatment failure rate and better patient‐reported quality‐of‐life outcomes. Although associated with de novo overactive bladder and groin pain, the higher success rate of TOT suggests it may be a more reliable surgical option for SUI. ClinicalTrials.gov registration number: NCT04775186.
- 11 August 2026
- Published by Wiley in Neurourology and Urodynamics
Laparoscopic Burch Colposuspension Versus Transobturator Tape for the Treatment of Stress Urinary Incontinence in Egyptian Women: A 12‐Month Randomized Controlled Trial
Aims: This study aimed to compare the efficacy, safety, and patient‐reported outcomes of laparoscopic Burch colposuspension versus the transobturator tape (TOT) midurethral sling procedure for treating stress urinary incontinence (SUI) in Egyptian women. Methods: This was a randomized, open‐label clinical trial conducted in Assiut, Egypt between January 2021 and December 2023. Fifty‐two women with SUI were randomly assigned to two groups of 26 patients each: Group A underwent the TOT procedure, and Group B underwent laparoscopic Burch colposuspension. The primary outcome was the improvement of SUI, assessed by a cough stress test. Secondary outcomes included changes in symptom severity and quality of life, measured by the Urogenital Distress Inventory (UDI‐6) and the Incontinence Impact Questionnaire (IIQ‐7). Patients were evaluated at 3, 6, and 12 months postoperatively. Results: Operative and anesthesia times were significantly longer for the laparoscopic colposuspension group ( p < 0.001). At 12 months, the treatment failure rate was significantly higher in the colposuspension group (34.6%) compared to the TOT group (7.7%) ( p = 0.017). While both groups initially improved, the SUI subscale scores on the UDI‐6 for the colposuspension group worsened after 3 months, becoming significantly worse than the TOT group at 6 and 12 months ( p = 0.004 at 12 months). Similarly, at 12 months, the TOT group reported significantly better quality‐of‐life scores on the IIQ‐7 ( p = 0.04). Multivariate binary logistic regression identified laparoscopic Burch colposuspension as a significant predictor of treatment failure (Odds Ratio: 7.02, p = 0.01). Overactive bladder was more common after TOT, whereas recurrence was more frequent after colposuspension ( p = 0.02). Conclusions: While both procedures initially improve SUI, the TOT procedure provides superior and more sustained efficacy over a 12‐month period in this cohort of Egyptian women. The TOT group had a significantly lower treatment failure rate and better patient‐reported quality‐of‐life outcomes. Although associated with de novo overactive bladder and groin pain, the higher success rate of TOT suggests it may be a more reliable surgical option for SUI. ClinicalTrials.gov registration number: NCT04775186.
- Open Access
- 15 January 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Optimal duration of perioperative antibiotics in radical cystectomy and urinary diversion: a systematic review and meta-analysis
Purpose: To evaluate the impact of extended versus nonextended perioperative antibiotic prophylaxis (PAP) on reducing postoperative complications and hospital stays in patients undergoing radical cystectomy and urinary diversion. Methods: We conducted this systematic review and meta-analysis in accordance with the PRISMA guidelines. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and the Cochrane Library for studies comparing short-term (≤ 24 h) and extended (≥ 24 h) PAP in patients undergoing radical cystectomy and urinary diversion. The primary outcomes were surgical site infections (SSIs), urinary tract infections (UTIs), and length of hospital stay. The statistical analysis was performed via RevMan version 5.3. The results are presented as risk ratios (RRs) and mean differences (MDs). Results are presented as risk ratios (RRs) and mean differences (MDs). The quality of evidence was assessed using the GRADE methodology. Results: A total of 214 studies were screened. Four studies involving 680 patients were included. No significant differences were detected between short-term and extended PAP in terms of SSIs (RR = 0.71 [95% CI 0.43–1.17]; P = 0.18]), febrile UTIs (RR = 1.19 [95% CI 0.91–1.56]; P = 0.20]), or length of hospital stay (MD = 0.76 days [95% CI [-2.72, 4.25]; P = 0.67]). Conclusion: No significant difference was observed between 24-h and extended PAP for reducing postoperative complications after radical cystectomy and urinary diversion. Short-term PAP is a reliable and effective strategy and is recommended as the standard practice for reducing antimicrobial resistance and improving postoperative outcomes.
- 15 January 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Open AccessOptimal duration of perioperative antibiotics in radical cystectomy and urinary diversion: a systematic review and meta-analysis
Purpose: To evaluate the impact of extended versus nonextended perioperative antibiotic prophylaxis (PAP) on reducing postoperative complications and hospital stays in patients undergoing radical cystectomy and urinary diversion. Methods: We conducted this systematic review and meta-analysis in accordance with the PRISMA guidelines. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and the Cochrane Library for studies comparing short-term (≤ 24 h) and extended (≥ 24 h) PAP in patients undergoing radical cystectomy and urinary diversion. The primary outcomes were surgical site infections (SSIs), urinary tract infections (UTIs), and length of hospital stay. The statistical analysis was performed via RevMan version 5.3. The results are presented as risk ratios (RRs) and mean differences (MDs). Results are presented as risk ratios (RRs) and mean differences (MDs). The quality of evidence was assessed using the GRADE methodology. Results: A total of 214 studies were screened. Four studies involving 680 patients were included. No significant differences were detected between short-term and extended PAP in terms of SSIs (RR = 0.71 [95% CI 0.43–1.17]; P = 0.18]), febrile UTIs (RR = 1.19 [95% CI 0.91–1.56]; P = 0.20]), or length of hospital stay (MD = 0.76 days [95% CI [-2.72, 4.25]; P = 0.67]). Conclusion: No significant difference was observed between 24-h and extended PAP for reducing postoperative complications after radical cystectomy and urinary diversion. Short-term PAP is a reliable and effective strategy and is recommended as the standard practice for reducing antimicrobial resistance and improving postoperative outcomes.